US6956032B1
(en)
*
|
1986-04-18 |
2005-10-18 |
Carnegie Mellon University |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
|
US6385487B1
(en)
|
1996-05-08 |
2002-05-07 |
Biophoretic Therapeutic Systems, Llc |
Methods for electrokinetic delivery of medicaments
|
US5676648A
(en)
|
1996-05-08 |
1997-10-14 |
The Aps Organization, Llp |
Iontophoretic drug delivery apparatus and method for use
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
KR20000035801A
(en)
*
|
1996-10-30 |
2000-06-26 |
에버트 챨스 디 |
Fatty acid esters of lactic acid salts as permeation enhancers
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
USRE37796E1
(en)
|
1997-12-16 |
2002-07-23 |
Biophoretic Therapeutic Systems, Llc |
Methods for iontophoretic delivery of antiviral agents
|
US6267984B1
(en)
|
1997-12-22 |
2001-07-31 |
Alza Corporation |
Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
WO2000010531A1
(en)
*
|
1998-08-19 |
2000-03-02 |
Rtp Pharma Inc. |
Injectable aqueous dispersions of propofol
|
US6148231A
(en)
*
|
1998-09-15 |
2000-11-14 |
Biophoretic Therapeutic Systems, Llc |
Iontophoretic drug delivery electrodes and method
|
US7919109B2
(en)
*
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7127285B2
(en)
*
|
1999-03-12 |
2006-10-24 |
Transport Pharmaceuticals Inc. |
Systems and methods for electrokinetic delivery of a substance
|
US6477410B1
(en)
|
2000-05-31 |
2002-11-05 |
Biophoretic Therapeutic Systems, Llc |
Electrokinetic delivery of medicaments
|
US6792306B2
(en)
*
|
2000-03-10 |
2004-09-14 |
Biophoretic Therapeutic Systems, Llc |
Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
|
DE19918105C1
(en)
*
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermal patch for administering neuroleptic agent i.e. fluphenazine, flupentixol or triflupromazine, includes matrix layer containing penetration enhancer and hydrocarbon polymer
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
PT1328273E
(en)
*
|
2000-10-23 |
2008-09-23 |
Euro Celtique Sa |
Felodipine transdermal device and methods
|
US7018649B2
(en)
|
2000-10-23 |
2006-03-28 |
Euro-Celtique, S.A. |
Felodipine transdermal device and methods
|
RU2708563C2
(en)
*
|
2001-03-16 |
2019-12-10 |
Алза Корпорейшн |
Transdermal patch for administering fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
JP2005508888A
(en)
*
|
2001-08-14 |
2005-04-07 |
バイオティ セラピーズ コーポレイション |
How to treat alcoholism or alcoholism
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
CN1720028A
(en)
|
2002-04-23 |
2006-01-11 |
阿尔扎公司 |
Transdermal analgesic systems with reduced abuse potential
|
US20040033255A1
(en)
|
2002-06-10 |
2004-02-19 |
Baker Carl J. |
Transdermal delivery device disposal system
|
ATE423560T1
(en)
*
|
2002-08-20 |
2009-03-15 |
Euro Celtique Sa |
TRANSDERMAL DOSAGE FORM CONTAINING AN ACTIVE INGREDIENT AND AN ANTAGONIST IN FREE BASE AND IN SALT FORM
|
CN100340395C
(en)
*
|
2002-08-30 |
2007-10-03 |
阿尔扎公司 |
Multilaminate backing construction
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
CA2534238A1
(en)
|
2003-07-28 |
2005-02-10 |
Alza Corporation |
Transdermal warfarin-containing delivery system
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
CA2543610A1
(en)
|
2003-10-30 |
2005-05-19 |
Alza Corporation |
Transdermal analgesic systems having reduced abuse potential
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
JP5254616B2
(en)
|
2004-09-13 |
2013-08-07 |
クロノ セラピューティクス、インコーポレイテッド |
Biosynchronous transdermal drug delivery
|
CN100425233C
(en)
*
|
2005-01-12 |
2008-10-15 |
复旦大学 |
Nimodipine gel for nasal cavity
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US8299025B2
(en)
|
2005-02-03 |
2012-10-30 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
PL1895994T3
(en)
*
|
2005-05-13 |
2011-02-28 |
Alza Corp |
Multilayer drug delivery system with barrier against reservoir material flow
|
WO2007010900A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Transcu Ltd. |
Percutaneous absorption patch with application position indicating function, and iontophoresis device
|
WO2007011763A2
(en)
*
|
2005-07-15 |
2007-01-25 |
3M Innovative Properties Company |
Adhesive sheet and methods of use thereof
|
US20070134310A1
(en)
*
|
2005-09-23 |
2007-06-14 |
Nedberge Diane E |
Transdermal risperidone delivery system
|
US8383149B2
(en)
*
|
2005-09-23 |
2013-02-26 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
US9056061B2
(en)
*
|
2005-09-23 |
2015-06-16 |
Alza Corporation |
Transdermal nicotine salt delivery system
|
WO2007035941A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal galantamine delivery system
|
DK1937276T3
(en)
|
2005-10-12 |
2013-02-11 |
Besins Healthcare Luxembourg |
IMPROVED TESTOSTERONGEL AND PROCEDURE TO USE THEREOF
|
WO2007079193A2
(en)
|
2005-12-30 |
2007-07-12 |
Tti Ellebeau, Inc. |
Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
|
KR101106510B1
(en)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
KR101200728B1
(en)
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
Osmotic delivery system and piston assemblies
|
US20080193514A1
(en)
*
|
2006-11-02 |
2008-08-14 |
Transcu Ltd. |
Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
|
EP2123259A1
(en)
*
|
2007-01-16 |
2009-11-25 |
Hokkaido University |
Liposome preparation for iontophoresis having antioxidant component encapsulated therein
|
JP2010187707A
(en)
*
|
2007-06-12 |
2010-09-02 |
Hokkaido Univ |
Liposome preparation for iontophoresis comprising insulin encapsulated therein
|
CN104398496B
(en)
*
|
2007-10-15 |
2018-03-20 |
阿尔扎公司 |
Change a transdermal administration in one day of fentanyl
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US20100069877A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Smith Gregory A |
Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
|
CN104523661A
(en)
*
|
2009-02-06 |
2015-04-22 |
南加利福尼亚大学 |
Therapeutic compositions comprising monoterpenes
|
HUE035862T2
(en)
|
2009-09-28 |
2018-05-28 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US8507734B2
(en)
|
2010-03-03 |
2013-08-13 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US20130017259A1
(en)
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
JP6285866B2
(en)
|
2011-11-23 |
2018-02-28 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
Natural complex hormone replacement preparations and therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11547676B2
(en)
*
|
2012-12-28 |
2023-01-10 |
Teikoku Seiyaku Co., Ltd. |
Extended buprenorphine transdermal delivery compositions and methods for using the same
|
WO2015178438A1
(en)
*
|
2014-05-20 |
2015-11-26 |
アルケア株式会社 |
Adhesive agent composition for skin and patch material for skin
|
AU2015264003A1
(en)
|
2014-05-22 |
2016-11-17 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
MX2016013693A
(en)
|
2014-07-29 |
2017-10-31 |
Therapeuticsmd Inc |
Transdermal cream.
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10213586B2
(en)
|
2015-01-28 |
2019-02-26 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
JP2018511127A
(en)
|
2015-03-12 |
2018-04-19 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
Craving input and support system
|
EP3302354B1
(en)
|
2015-06-03 |
2023-10-04 |
i2o Therapeutics, Inc. |
Implant placement systems
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
BR112018073511A2
(en)
|
2016-05-16 |
2019-03-26 |
Intarcia Therapeutics, Inc. |
glucagon receptor selective polypeptides and methods of use
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CN110225762A
(en)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
The method of the co-administration of continuous administration and drug including GLP-1 receptor stimulating agent
|
JP2020503950A
(en)
|
2017-01-06 |
2020-02-06 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
Device and method for transdermal drug delivery
|
DK3749291T3
(en)
|
2018-02-08 |
2024-04-08 |
Univ Southern California |
METHODS OF PERMEABILIZING THE BLOOD-BRAIN BARRIER
|
WO2019232077A1
(en)
|
2018-05-29 |
2019-12-05 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
CN109700601B
(en)
*
|
2019-02-02 |
2022-04-22 |
天津嘉氏堂科技有限公司 |
Hydrocolloid silicon dressing patch
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|